- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
January 31, 2023Christopher Larus Named Finalist for Legaltech News’ Leaders in Tech Law Award for Innovator of The Year
-
January 30, 2023David Martinez Named To 2023 Leaders of Influence: Minority Attorneys by Los Angeles Business Journal
-
January 25, 2023Roman Silberfeld Named to Daily Journal’s Inaugural Leading Commercial Litigators List
-
February 17-18, 2023MAJ 2023 Mid-Winter Meeting
-
March 3, 2023LGBTQ Legal Services: Transgender Name Change Clinic
-
March 19-22, 2023PLRB 2023 Claims Conference
-
Fourth QuarterGenerically Speaking: A Hatch-Waxman Litigation Bulletin
-
Fourth QuarterANDA Approvals
-
January 24, 2023Briefly: Column to Continue With New Authors at Helm
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Consumer Alert: FOSAMAX® May Cause Osteonecrosis ("Jaw Death")
April 12, 2006
FOSAMAX® is a medicine in the bisphosphonates family that is prescribed widely to prevent bone loss or the decrease of bone density. It is commonly used by post-menopausal women. There have been reports that persons taking FOSAMAX® have developed a severe problem in which bone in their jaws dies. This “jaw death” (also referred to jaw necrosis or jaw decay) often appears after minor trauma such as a tooth extraction. According to press reports, the American Association of Endodontists recently released a position paper that cautions that many patients who take FOSAMAX® may be at risk this terrible complication. Other bisphosphonates such as Actonel may also be implicated.
If you or someone you know has taken FOSAMAX® and has suffered jaw injuries, you may wish to contact us. Please call Gary Wilson or Tara Sutton at 612-349-8500 or e-mail them at this link: contact us.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.